AU Patent

AU2016262644B2 — Intravenous antiviral treatments

Assigned to Biocryst Pharmaceuticals Inc · Expires 2018-12-20 · 7y expired

What this patent protects

The invention provides unit dosage forms, kits and methods for treating viral infections.

USPTO Abstract

The invention provides unit dosage forms, kits and methods for treating viral infections.

Drugs covered by this patent

Patent Metadata

Patent number: AU2016262644B2
Jurisdiction: AU
Classification: —
Expires: 2018-12-20
Drug substance claim: No
Drug product claim: No
Assignee: Biocryst Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.